Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer

dc.contributor.authorPadya B.S.
dc.contributor.authorPandey A.
dc.contributor.authorPisay M.
dc.contributor.authorKoteshwara K.B.
dc.contributor.authorChandrashekhar Hariharapura R.
dc.contributor.authorBhat K U.
dc.contributor.authorBiswas S.
dc.contributor.authorMutalik S.
dc.date.accessioned2021-05-05T10:11:46Z
dc.date.available2021-05-05T10:11:46Z
dc.date.issued2021
dc.description.abstractInterdisciplinary applications of nanopharmaceutical sciences have tremendous potential for enhancing pharmacokinetics, efficacy and safety of cancer therapy. The limitations of conventional therapeutic platforms used for skin cancer therapy have been largely overcome by the use of nanoplatforms. This review discusses various nanotechnological approaches experimented for the treatment of skin cancer. The review describes various polymeric, lipidic and inorganic nanoplatforms for efficient therapy of skin cancer. The stimuli-responsive nanoplatforms such as pH-responsive as well as temperature-responsive platforms have also been reviewed. Different strategies for potentiating the nanoparticles application for cancer therapy such as surface engineering, conjugation with drugs, stimulus-responsive and multimodal effect have also been discussed and compared with the available conventional treatments. Although, nanopharmaceuticals face challenges such as toxicity, cost and scale-up, efforts put-in to improve these drawbacks with continuous research would deliver exciting and promising results in coming days. © 2020 Elsevier B.V.en_US
dc.identifier.citationEuropean Journal of Pharmacology , Vol. 890 , , p. -en_US
dc.identifier.urihttps://doi.org/10.1016/j.ejphar.2020.173633
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/14653
dc.titleStimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin canceren_US
dc.typeReviewen_US

Files